14 SPACs That Palantir Technologies Has Invested In Or Partnered
Palantir Technologies Inc (NYSE: PLTR) is one of the most well-known publicly traded companies. The data analytics company is increasing its investments in the SPAC space, which caught the attention of Barron’s recently.
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)
77 Biggest Movers From Yesterday
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
Longeveron’s Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS
Photo by Anna Shvets from Pexels
EXCLUSIVE: Celularity’s CEO On ‘One-Size-Fits-All’ Product, Palantir Connection
Former PepsiCo Inc (NASDAQ: PEP) president and Apple Inc (NASDAQ: AAPL) CEO John Sculley raved about Celularity Inc (NASDAQ: